NovoCure Ltd

Research NovoCure Ltd (NVCR) on Bullrun: market cap USD 1.79B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNVCR
• ExchangeNASDAQ
• CountrySwitzerland
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 1.79B
• Financial periodFY2025
• RevenueUSD 655.35M
• Revenue growth8.3%
• Net income-USD 136.23M
• Free cash flow-USD 75.68M
• Gross margin74.5%

Valuation Snapshot

latest market cap is USD 1.79B.

About NovoCure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax.

Frequently asked questions

What is NovoCure Ltd's market cap?

NovoCure Ltd's market capitalization is USD 1.79B.

What does NovoCure Ltd do?

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally.